Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

Proof of Concept for the Safety and Immunogenicity of Lymph Node...

Ogkologos - 18 Ιανουαρίου, 2024

Qué debo saber sobre la mastectomía con cierre plano después de...

Ogkologos - 17 Ιανουαρίου, 2024

EMA Recommends Granting a Marketing Authorisation for Pomalidomide Viatris

Ogkologos - 17 Ιανουαρίου, 2024

Cancer in My Community: Developing Pediatric Palliative and Supportive Care in...

Ogkologos - 16 Ιανουαρίου, 2024

The First Report from the Cancer Programme of the 100,000 Genomes...

Ogkologos - 16 Ιανουαρίου, 2024

Durable Activity of Repotrectinib in Patients with ROS1 Fusion–Positive NSCLC Regardless...

Ogkologos - 15 Ιανουαρίου, 2024

For People with Inherited Risk of Stomach Cancer, Gastrectomy Has Lasting...

Ogkologos - 12 Ιανουαρίου, 2024

EMA Recommends Granting a Marketing Authorisation for Generic Eribulin

Ogkologos - 12 Ιανουαρίου, 2024

Using a Mind-Body Connection to Help You Cope During Cancer: An...

Ogkologos - 11 Ιανουαρίου, 2024

Neoadjuvant Atezolizumab Plus Chemotherapy Is Safe and Has Promising Activity in...

Ogkologos - 11 Ιανουαρίου, 2024

1...959697...440 Σελίδα 96 από 440

MOST POPULAR

Disguising Cancer as an Infection Helps the Immune System Eliminate Tumors

22 Ιουλίου, 2022

A Combination of Osimertinib Plus Pemetrexed and a Platinum-based Agent Significantly...

29 Νοεμβρίου, 2023

American tobacco company Philip Morris International offers £1bn for UK pharma...

9 Ιουλίου, 2021

Immune-Modulating SBRT Plus Anti-PD-L1 May Convert Immune-Cold ER-positive, HER2-negative EBC Into...

3 Αυγούστου, 2026

Φόρτωση περισσοτέρων

Proof of Concept for the Safety and Immunogenicity of Lymph Node...

Qué debo saber sobre la mastectomía con cierre plano después de...

EMA Recommends Granting a Marketing Authorisation for Pomalidomide Viatris

Cancer in My Community: Developing Pediatric Palliative and Supportive Care in...

The First Report from the Cancer Programme of the 100,000 Genomes...

Durable Activity of Repotrectinib in Patients with ROS1 Fusion–Positive NSCLC Regardless...

For People with Inherited Risk of Stomach Cancer, Gastrectomy Has Lasting...

EMA Recommends Granting a Marketing Authorisation for Generic Eribulin

Using a Mind-Body Connection to Help You Cope During Cancer: An...

Neoadjuvant Atezolizumab Plus Chemotherapy Is Safe and Has Promising Activity in...

MOST POPULAR

Disguising Cancer as an Infection Helps the Immune System Eliminate Tumors

A Combination of Osimertinib Plus Pemetrexed and a Platinum-based Agent Significantly...

American tobacco company Philip Morris International offers £1bn for UK pharma...

Immune-Modulating SBRT Plus Anti-PD-L1 May Convert Immune-Cold ER-positive, HER2-negative EBC Into...

HOT NEWS

Overcoming a Cancer Nemesis? KRAS Inhibitor Shows Promise in Early Trial

EMA Recommends Granting a Marketing Authorisation for Lurbinectedin

Using a Blood Test to Select Treatments for Advanced Gastrointestinal Stromal...

The director’s cut: How Dr Catherine Elliott sees the future of...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ